Explains how genetics may affect an individual's susceptibility to nicotine addiction, and discusses the debate over genetic predisposition to nicotine addiction versus a person's upbringing.
Looks at the issue of marketing antidepressants, discussing how the advertising of these drugs has opened pharmaceutical companies to skepticism and criticism.